AwesomeCapital
Search This Blog
Monday, June 3, 2019
Trevi started at Buy by Needham
Target $18
https://www.benzinga.com/stock/TRVI/ratings
Trevi started at Outperform by BMO
Target $15
https://www.benzinga.com/stock/TRVI/ratings
Trevi started at Buy by Stifel
Target $20
https://www.benzinga.com/stock/TRVI/ratings
Teva upped to Outperform by Oppenheimer
From Perform; target $12
https://www.benzinga.com/stock/TEVA/ratings
NextCure started at Overweight by Morgan Stanley
Target $25
https://www.benzinga.com/stock/NXTC/ratings
NextCure started at Overweight by Piper Jaffray
Target $26.
https://www.benzinga.com/stock/NXTC/ratings
Molina upped to Outperform by BMO
From Market Perform; target to $200 from $154.
https://www.benzinga.com/stock/MOH/ratings
Newer Posts
Older Posts
Home
Subscribe to:
Comments (Atom)